CLINICAL STUDIES WITH AZETEPA IN THE TREATMENT OF ADVANCED CANCER.
D001389:Azirines; D001859:Bone Neoplasms; D002283:Carcinoma, Bronchogenic; D002294:Carcinoma, Squamous Cell; D002296:Carcinosarcoma; D004806:Ependymoma; D005354:Fibrosarcoma; D005770:Gastrointestinal Neoplasms; D005853:Geriatrics; D006689:Hodgkin Disease; D006801:Humans; D008223:Lymphoma; D008224:Lymphoma, Follicular; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D008654:Mesothelioma; D009062:Mouth Neoplasms; D009101:Multiple Myeloma; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds; D010610:Pharyngeal Neoplasms
D001389:Azirines; D009588:Nitrogen Mustard Compounds; C025817:azetepa
BONE NEOPLASMS; CARCINOMA, BRONCHOGENIC; CARCINOMA, EPIDERMOID; CARCINOSARCOMA; EPENDYMOMA; FIBROSARCOMA; GASTROINTESTINAL NEOPLASMS; GERIATRICS; HODGKIN'S DISEASE; LYMPHOMA, GIANT FOLLICULAR; LYMPHOSARCOMA; MELANOMA; MESOTHELIOMA; MOUTH NEOPLASMS; MULTIPLE MYELOMA; NITROGEN MUSTARD COMPOUNDS; PHARYNGEAL NEOPLASMS